Mesenchymal stromal cells use PGE2 to modulate activation and proliferation of lymphocyte subsets: Combined comparison of adipose tissue, Wharton's Jelly and bone marrow sources
Mesenchymal stromal cells use PGE2 to modulate activation and proliferation of lymphocyte subsets: Combined comparison of adipose tissue, Wharton's Jelly and bone marrow sources
复制标题
DOI:
10.1016/j.cellimm.2010.06.006
复制
发表时间:
2010-01-01
影响因子:
4.3
通讯作者:
Lagneaux, Laurence
中科院分区:
文献类型:
--
作者:
Najar, Mehdi;Raicevic, Gordana;Lagneaux, Laurence
Due to their immunomodulatory properties, adipose tissue (AT) and Wharton's Jelly (WJ) constitute valuable alternatives to BM as sources of MSCs for managing graft-versus-host disease To ensure the efficiency of AT- and WJ-MSCs implies the characterization of their immunomodulatory functions in comparison to those of BM In this study, we investigated the capacity of AT- and WJ-MSCs to modulate lymphocyte ieactions in response to different stimuli as well as the specificity of this immunomodulanon AT- and WJ-MSC displayed potent immunosuppressive effects on lymphocyte responses in a dose-dependent manner These effects included the prevention of lymphocyte activation as well as the suppression of T-cell proliferation regardless of the stimuli used to activate lymphocytes These effects were mediated through the expression of COX1/C0X2 enzymes and by the production of PGE2 CD4(+) and CD8(+) T-lymphocytes were equally targeted by MSCs demonstrating that the immunomodulation was not restricted to a specific T-cell subpopulation (C) 2010 Elsevier Inc All rights reserved